YANGI AVLOD ANTIBIOTIKLARI VA ANTIBIOTIKKA CHIDAMLILIK MUAMMOSI

Authors

  • Muxiddinov X.M. Siyob Abu Ali ibn Sino nomidagi Jamoatsalomatligi texnikumi tibbiy kimyo fani o‘qituvchisi

Keywords:

antibiotikga chidamlilik, AMR, yangi avlod antibiotiklar, tibbiy kimyo, gepotidacin, zosurabalpin, Gram-manfiy bakteriyalar.

Abstract

Antibiotikka chidamlilik (AMR — Antimicrobial Resistance) global sog‘liqni saqlashning eng jiddiy tahdidlaridan biri hisoblanadi. Jahon sog‘liqni saqlash tashkiloti (JSST) ma’lumotlariga ko‘ra, 2023 yilda har oltinchi laboratoriyada tasdiqlangan bakterial infeksiya antibiotiklarga chidamli bo‘lgan. Ushbu maqolada AMR ning hozirgi holati, mexanizmlari, yangi avlod antibiotiklarning tibbiy kimyoviy asoslari va ularning muammoni yumshatishdagi roli adabiyotlar tahlili asosida batafsil yoritilgan. Natijalar shuni ko‘rsatadiki, gepotidacin, zosurabalpin kabi yangi mexanizmli antibiotiklar umidvor bo‘lsa-da, pipeline tor va kompleks yondashuv talab etiladi.

References

World Health Organization. Global antibiotic resistance surveillance report 2025: WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS). Geneva: World Health Organization, 2025. 138 s.

Naghavi M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 // The Lancet. 2024. Vol. 404, № 10459. P. 1199–1226. DOI: 10.1016/S0140-6736(24)01867-1.

Zampaloni C. A novel antibiotic class targeting the lipopolysaccharide transporter // Nature. 2024. Vol. 625. P. 566–574. DOI: 10.1038/s41586-023-06873-0.

Glaxo S.K. Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urinary tract infections. London, 2025. (Press-reliz).

Jesudason T. et al. Antibacterial agents in preclinical and clinical development // The Lancet Microbe. 2024. DOI: 10.1016/S2666-5247(24)00215-5.

Downloads

Published

2026-05-20

How to Cite

Muxiddinov X.M. (2026). YANGI AVLOD ANTIBIOTIKLARI VA ANTIBIOTIKKA CHIDAMLILIK MUAMMOSI. IQRO , 21(2), 1401–1403. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/7356